BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17434873)

  • 1. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells.
    Ranjith-Kumar CT; Miller W; Sun J; Xiong J; Santos J; Yarbrough I; Lamb RJ; Mills J; Duffy KE; Hoose S; Cunningham M; Holzenburg A; Mbow ML; Sarisky RT; Kao CC
    J Biol Chem; 2007 Jun; 282(24):17696-705. PubMed ID: 17434873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.
    de Bouteiller O; Merck E; Hasan UA; Hubac S; Benguigui B; Trinchieri G; Bates EE; Caux C
    J Biol Chem; 2005 Nov; 280(46):38133-45. PubMed ID: 16144834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.
    Studzińska M; Jabłońska A; Wiśniewska-Ligier M; Nowakowska D; Gaj Z; Leśnikowski ZJ; Woźniakowska-Gęsicka T; Wilczyński J; Paradowska E
    PLoS One; 2017; 12(1):e0169420. PubMed ID: 28046022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-time PCR assay for the simultaneous detection of functional N284I and L412F polymorphisms in the human Toll-like receptor 3 gene.
    Brown RA; Razonable RR
    J Mol Diagn; 2010 Jul; 12(4):493-7. PubMed ID: 20413676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity.
    Zhou P; Fan L; Yu KD; Zhao MW; Li XX
    FASEB J; 2011 Oct; 25(10):3489-95. PubMed ID: 21712495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.
    Cooke G; Kamal I; Strengert M; Hams E; Mawhinney L; Tynan A; O'Reilly C; O'Dwyer DN; Kunkel SL; Knaus UG; Shields DC; Moller DR; Bowie AG; Fallon PG; Hogaboam CM; Armstrong ME; Donnelly SC
    QJM; 2018 Apr; 111(4):217-224. PubMed ID: 29237089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
    O'Dwyer DN; Armstrong ME; Trujillo G; Cooke G; Keane MP; Fallon PG; Simpson AJ; Millar AB; McGrath EE; Whyte MK; Hirani N; Hogaboam CM; Donnelly SC
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1442-50. PubMed ID: 24070541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the European rabbit (Oryctolagus cuniculus) innate immune system: genetic diversity of the toll-like receptor 3 (TLR3) in wild populations and domestic breeds.
    Abrantes J; Areal H; Esteves PJ
    BMC Genet; 2013 Aug; 14():73. PubMed ID: 23964588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between a functional polymorphism in Toll-like receptor 3 and chronic hepatitis C in liver transplant recipients.
    Lee SO; Brown RA; Razonable RR
    Transpl Infect Dis; 2013 Apr; 15(2):111-9. PubMed ID: 23240626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the dynamic nature of the dsRNA-bound TLR3 complex.
    Gosu V; Son S; Shin D; Song KD
    Sci Rep; 2019 Mar; 9(1):3652. PubMed ID: 30842554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of genetic variants in the porcine TLR3 gene.
    Wang L; Chen YC; Zhang DJ; Li HT; Liu D; Yang XQ
    Genet Mol Res; 2014 Feb; 13(1):1348-57. PubMed ID: 24634233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1.
    Qi R; Hoose S; Schreiter J; Sawant KV; Lamb R; Ranjith-Kumar CT; Mills J; San Mateo L; Jordan JL; Kao CC
    J Biol Chem; 2010 Nov; 285(47):36635-44. PubMed ID: 20855885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity.
    Nahum A; Dadi H; Bates A; Roifman CM
    Autoimmun Rev; 2012 Mar; 11(5):341-7. PubMed ID: 22024499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain.
    Watanabe T; Ito K; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2006; (50):251-2. PubMed ID: 17150912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal binding site in the human toll-like receptor 3 ectodomain.
    Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 L412F polymorphisms in infants with bronchiolitis and postbronchiolitis wheezing.
    Nuolivirta K; He Q; Vuononvirta J; Koponen P; Helminen M; Korppi M
    Pediatr Infect Dis J; 2012 Sep; 31(9):920-3. PubMed ID: 22549436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the N-terminal histidine-rich region for the function of the human toll-like receptor 3 ectodomain.
    Tokisue T; Watanabe T; Tsujita T; Nishikawa S; Hasegawa T; Seya T; Matsumoto M; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2008; (52):203-4. PubMed ID: 18776324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of the Toll-like receptor 3 and a putative Toll-like receptor 3 antagonist encoded by the African swine fever virus.
    Henriques ES; Brito RM; Soares H; Ventura S; de Oliveira VL; Parkhouse RM
    Protein Sci; 2011 Feb; 20(2):247-55. PubMed ID: 21280117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements.
    Nishiya T; Kajita E; Miwa S; Defranco AL
    J Biol Chem; 2005 Nov; 280(44):37107-17. PubMed ID: 16105838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    McElroy AN; Invernizzi R; Laskowska JW; O'Neill A; Doroudian M; Moghoofei M; Mostafaei S; Li F; Przybylski AA; O'Dwyer DN; Bowie AG; Fallon PG; Maher TM; Hogaboam CM; Molyneaux PL; Hirani N; Armstrong ME; Donnelly SC
    Am J Respir Crit Care Med; 2022 Mar; 205(5):550-562. PubMed ID: 34985402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.